TREA

87278812 - T TITAN PHARMACEUTICALS

Follow

Information

  • Trademark
  • 87278812
  • Serial Number
    87278812
  • Registration Number
    5782129
  • Filing Date
    December 22, 2016
    7 years ago
  • Registration Date
    June 18, 2019
    5 years ago
  • Transaction Date
    June 18, 2024
    5 months ago
  • Status Date
    June 18, 2019
    5 years ago
  • Published for Opposition Date
    August 28, 2018
    6 years ago
  • Location Date
    May 16, 2019
    5 years ago
  • First Use Anywhere Date
    February 26, 2019
    5 years ago
  • First Use In Commerce Date
    February 26, 2019
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    FERRAIUOLO, DOMINIC J
  • Attorney Docket Number
    304146023000
    Attorney Name
    Jennifer Lee Taylor
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
3
Mark Identification
T TITAN PHARMACEUTICALS
Case File Statements
  • DM0000: The mark consists of the stylized wording "TITAN PHARMACEUTICALS" in black adjacent to a design comprising a stylized letter "T" with the left half in color red, a triangle in color red with a dot in the middle in color white and the rest of the letter "T" in color white.
  • GS0051: Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
  • CC0000: The color(s) red, black and white is/are claimed as a feature of the mark.
  • DS0000: "PHARMACEUTICALS"
Case File Event Statements
  • 12/27/2016 - 7 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/6/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/7/2017 - 7 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 1/8/2017 - 7 years ago
    4 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 9/15/2017 - 7 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/8/2017 - 7 years ago
    5 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA
  • 3/22/2017 - 7 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/29/2017 - 7 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/29/2017 - 7 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/29/2017 - 7 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/15/2017 - 7 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/9/2017 - 7 years ago
    13 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 9/15/2017 - 7 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/25/2018 - 6 years ago
    22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/9/2017 - 7 years ago
    14 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 10/9/2017 - 7 years ago
    15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 3/28/2018 - 6 years ago
    16 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 4/13/2018 - 6 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 4/17/2018 - 6 years ago
    18 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 7/25/2018 - 6 years ago
    19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/25/2018 - 6 years ago
    20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/25/2018 - 6 years ago
    21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/25/2018 - 6 years ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/8/2018 - 6 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/28/2018 - 6 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/28/2018 - 6 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/23/2018 - 6 years ago
    27 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/17/2019 - 5 years ago
    28 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/17/2019 - 5 years ago
    29 - SOU EXTENSION 1 FILED Type: EXT1
  • 4/17/2019 - 5 years ago
    30 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 4/23/2019 - 5 years ago
    32 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 4/19/2019 - 5 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/23/2019 - 5 years ago
    34 - USE AMENDMENT FILED Type: IUAF
  • 5/5/2019 - 5 years ago
    35 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 5/5/2019 - 5 years ago
    33 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/17/2019 - 5 years ago
    37 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 6/18/2019 - 5 years ago
    38 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/18/2024 - 5 months ago
    39 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 5/16/2019 - 5 years ago
    36 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR